Adherence to ASCO/CAP HER2 Testing Guidelines: Equivocal Rates and Impact on Management within a Single Institution

被引：0
|
作者：
Portier, B. P.
Downs-Kelly, E.
Lanigan, C.
Cotta, C.
Patil, D.
Procop, G.
Cook, J. R.
Moore, H.
Budd, G. T.
Tubbs, R. R.
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Taussig Canc Inst, Cleveland, OH USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1856
引用
收藏
页码：436A / 436A
页数：1
相关论文
共 50 条
  • [31] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Bo Wang
    Wei Ding
    Ke Sun
    Xiaoling Wang
    Liming Xu
    Xiaodong Teng
    Scientific Reports, 9
  • [32] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Wang, Bo
    Ding, Wei
    Sun, Ke
    Wang, Xiaoling
    Xu, Liming
    Teng, Xiaodong
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [33] Increase of Equivocal In Situ Hybridization Results in 2013 ASCO/CAP Guidelines for HER2 Testing in Invasive Breast Cancer: Comparison With the 2007 Criteria
    Espinet, Blanca
    Maria Puiggros, Anna
    Maria Corominas, Josep
    Iglesias, Mar
    Rodriguez-Rivera, Maria
    Carme Melero, Maria
    Albanell, Joan
    Tusquets, Ignacio
    Servitja, Sonia
    Serrano, Sergio
    Salido, Marta
    LABORATORY INVESTIGATION, 2015, 95 : 43A - 43A
  • [34] Increase of Equivocal In Situ Hybridization Results in 2013 ASCO/CAP Guidelines for HER2 Testing in Invasive Breast Cancer: Comparison With the 2007 Criteria
    Espinet, Blanca
    Maria Puiggros, Anna
    Maria Corominas, Josep
    Iglesias, Mar
    Rodriguez-Rivera, Maria
    Carme Melero, Maria
    Albanell, Joan
    Tusquets, Ignacio
    Servitja, Sonia
    Serrano, Sergio
    Salido, Marta
    MODERN PATHOLOGY, 2015, 28 : 43A - 43A
  • [35] Application of the ASCO/CAP guidelines for HER2 testing to mRNA expression values from microarrays
    Shaye, A. N.
    Gong, Y.
    Yan, K.
    Sneige, N.
    Esteva, F. J.
    Hortobagyi, G. N.
    Pusztai, L.
    Symmans, W. F.
    LABORATORY INVESTIGATION, 2008, 88 : 54A - 54A
  • [36] Application of the ASCO/CAP guidelines for HER2 testing to mRNA expression values from microarrays
    Shaye, A. N.
    Gong, Y.
    Sneige, N.
    Esteva, F. J.
    Hortobagyu, G. N.
    Pusztai, L.
    Symmans, W. F.
    MODERN PATHOLOGY, 2008, 21 : 54A - 54A
  • [37] Impact of Recent 2018 ASCO-CAP HER2 Testing Guidelines on 2713 Breast Cancer Cases Treated According to 2013 ASCO-CAP HER2 Guidelines: Western Indian Tertiary Cancer Centre Experience
    Pai, T.
    Ankolkar, M.
    Shetty, O.
    Gurav, M.
    Dhanavade, S.
    Kadam, V.
    Tambe, S.
    Patil, A.
    Desai, S.
    Shet, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1227 - 1227
  • [38] Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience
    Varga, Zsuzsanna
    Noske, Aurelia
    PLOS ONE, 2015, 10 (10):
  • [39] Effect of the new 2013 ASCO / CAP guidelines on HER2 reporting
    Gulbahce, H. Evin
    Factor, Rachel E.
    Downs-Kelly, Erinn
    Coppin, Margaret
    Geiersbach, Katherine B.
    CANCER RESEARCH, 2015, 75
  • [40] The Impact of 2013 ASCO/CAP Guidelines on the Breast Cancer Her2/Neu FISH Results
    Zhang, Songlin
    Wang, Xiaohong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S144 - S144
12345